Viral microbiome of prostate tissue in benign prostatic hyperplasia and prostate cancer
Authors:
- A. A. KamalovAKA. A. Kamalov
- L. M. MikhalevaLML. M. Mikhaleva
- V. K. KarpovVKV. K. Karpov
- D. A. OkhobotovDOD. A. Okhobotov
- T. B. TakhirzadeTTT. B. Takhirzade
- A. M. PshikhachevAPA. M. Pshikhachev
- O. Yu. NesterovaONO. Yu. Nesterova
- B. M. ShaparovBSB. M. Shaparov
- A. A. StrigunovASA. A. Strigunov
- V. V. PechnikovaVPV. V. Pechnikova
- O. A. OsmanovOOO. A. Osmanov
Open Access
- 9 May 2025
- journal article
- Published by Publishing House ABV Press in Cancer Urology
- Vol. 21 (1) , 25-34
Abstract
Aim. To evaluate the incidence of various viruses in prostate tissue in benign prostatic hyperplasia (BPH) and prostate cancer (PCa).Materials and methods. The study included 145 patients who were operated on for BPH (n = 79) or PCa (n = 66) in the period between 2019 and 2023. Real-time polymerase chain reaction was performed in the obtained samples of surgical material to determine the presence of human papillomavirus (HPV), herpes simplex viruses type 1 and 2, cytomegalovirus (CMV), Epstein–Barr virus (EBV), herpes virus type 6 (HHV-6).Results. Mean age of patients was 68.2 years. Viruses in prostate tissue were found in 40.7 % of patients in the total cohort: in 35.4 % of patients with BPH and in 47.0 % of patients with PCa (p = 0.159). The most common virus detected in the total cohort of patients was EBV which was found in 18.6 % of patients: in 16.5 % of patients with BPH and in 21.2 % of patients with PCa (p = 0.464). The second most common was HHV-6 (9.0 % of patients of the total cohort: 19.7 % of patients with PCa and in 0 % with BPH, p 0.001), and the third was CMV (7.6 % of patients: 2.5 % of patients with BPH and 13.6 % of patients with PCa, p = 0.027). When combining all HPV types, the prevalence of HPV was 10.3 %, but individual subtypes were found in isolated cases and their incidence in the total cohort did not exceed 2.1 %. The incidence of HPV (all types) was 16.5 % in patients with BPH and 3.0 % in patients with PCa (p = 0.018).Conclusion. In patients with prostate diseases, almost half of the cases have viral infection localized in the prostate tissue. CMV and HHV-6 are the most common in patients with PCa. The latter was not found in patients with BPH. EBV is equally represented among patients with BPH and PCa.Keywords
This publication has 28 references indexed in Scilit:
- Sexually and non‐sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP studyCancer Medicine, 2024
- Human papillomavirus and prostate cancer: systematic review and meta-analysisScientific Reports, 2023
- Viral etiology of prostate cancer: Genetic alterations and immune response. A literature reviewInternational Journal of Surgery, 2018
- Detection of DNA viruses in prostate cancerScientific Reports, 2016
- Sexually transmitted infections and prostate cancer risk: A systematic review and meta-analysisCancer Epidemiology, 2014
- Metagenomic sequencing of expressed prostate secretionsJournal of Medical Virology, 2014
- Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic reviewUrologic Oncology: Seminars and Original Investigations, 2013
- Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancerThe Prostate, 2012
- Die Detektion von Papillomavirus-DNA in der ProstataDer Urologe, 2008
- A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganismsThe Prostate, 2007